John Brown, Curtis Heisel, Nick Boucher, Nitika Aggarwal, Rusirini Fernando, Nikoo Hamzeh, Palak Patel, Mathew MacCumber, Manjot K Gill
{"title":"Analysis of Fellow Eye Posterior Vitreous Detachment and Complications Using a Large Database of Retina Specialists.","authors":"John Brown, Curtis Heisel, Nick Boucher, Nitika Aggarwal, Rusirini Fernando, Nikoo Hamzeh, Palak Patel, Mathew MacCumber, Manjot K Gill","doi":"10.1016/j.oret.2025.09.015","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To identify risk factors in diagnosis of second eye PVD after first eye PVD and subsequent complications.</p><p><strong>Methods: </strong>This multicenter, retrospective, observational study analyzed 22,525 patients with first eye PVD (2015-2024) from the CorEvitas Vestrum Health Database.</p><p><strong>Results: </strong>Of 22,525 patients, 38.3% were diagnosed with complications after first eye PVD within one year (24.3% vitreous hemorrhage [VH], 24.1% retinal break [RB], 5.2% retinal detachment [RD]). Second eye PVD occurred in 21.2% of the 22,525 patients. The median time to diagnosis of second eye PVD was 37 months, with 74.5% of patients diagnosed with a second eye PVD having it within 72 months. Increased risk of second eye PVD was associated with first eye VH (HR 1.08, p = 0.027), first eye RB (HR 1.13, p < 0.001), lattice degeneration in either eye (HR 1.09, p = 0.037), and pseudophakia in the second eye (HR 1.21, p < 0.001). Age > 65 (HR 0.79, p < 0.001) and male gender (HR 0.93, p = 0.022) reduced risk. 33.2% of eyes that experienced a second eye PVD had associated complications, of which 21.1% were detected within 12 months. Risk factors included male gender (HR 1.46, p < 0.001), lattice degeneration in either eye (HR 1.38, p < 0.001), and first eye VH (HR 2.09, p < 0.001), RB (HR 1.78, p < 0.001), or RD (HR 1.35, p = 0.004). Any complication in the first eye PVD (HR 3.66, p < 0.001) greatly increased risk. Age > 65 reduced complication risk (HR 0.77, p < 0.001).</p><p><strong>Conclusions: </strong>Following first eye PVD, second eye PVD may occur after several years, necessitating the need for continuous follow-up especially in higher risk groups such as younger patients, patients with first eye VH and RB, those with pseudophakia in the second eye, and those with lattice degeneration in either eye. Following onset of second eye PVD, high risk groups such as male patients, those with lattice degeneration in either eye, or any history of complications in the first eye PVD warrant closer and longer follow-up due to greater risk for complications after second eye PVD.</p>","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology. Retina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.oret.2025.09.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To identify risk factors in diagnosis of second eye PVD after first eye PVD and subsequent complications.
Methods: This multicenter, retrospective, observational study analyzed 22,525 patients with first eye PVD (2015-2024) from the CorEvitas Vestrum Health Database.
Results: Of 22,525 patients, 38.3% were diagnosed with complications after first eye PVD within one year (24.3% vitreous hemorrhage [VH], 24.1% retinal break [RB], 5.2% retinal detachment [RD]). Second eye PVD occurred in 21.2% of the 22,525 patients. The median time to diagnosis of second eye PVD was 37 months, with 74.5% of patients diagnosed with a second eye PVD having it within 72 months. Increased risk of second eye PVD was associated with first eye VH (HR 1.08, p = 0.027), first eye RB (HR 1.13, p < 0.001), lattice degeneration in either eye (HR 1.09, p = 0.037), and pseudophakia in the second eye (HR 1.21, p < 0.001). Age > 65 (HR 0.79, p < 0.001) and male gender (HR 0.93, p = 0.022) reduced risk. 33.2% of eyes that experienced a second eye PVD had associated complications, of which 21.1% were detected within 12 months. Risk factors included male gender (HR 1.46, p < 0.001), lattice degeneration in either eye (HR 1.38, p < 0.001), and first eye VH (HR 2.09, p < 0.001), RB (HR 1.78, p < 0.001), or RD (HR 1.35, p = 0.004). Any complication in the first eye PVD (HR 3.66, p < 0.001) greatly increased risk. Age > 65 reduced complication risk (HR 0.77, p < 0.001).
Conclusions: Following first eye PVD, second eye PVD may occur after several years, necessitating the need for continuous follow-up especially in higher risk groups such as younger patients, patients with first eye VH and RB, those with pseudophakia in the second eye, and those with lattice degeneration in either eye. Following onset of second eye PVD, high risk groups such as male patients, those with lattice degeneration in either eye, or any history of complications in the first eye PVD warrant closer and longer follow-up due to greater risk for complications after second eye PVD.
目的:探讨第一只眼PVD后第二只眼PVD诊断的危险因素及其并发症。方法:这项多中心、回顾性、观察性研究分析了来自CorEvitas Vestrum健康数据库的22525例第一眼PVD患者(2015-2024)。结果:22525例患者中,有38.3%的患者在一年内出现首发眼PVD并发症(其中玻璃体出血[VH]占24.3%,视网膜破裂[RB]占24.1%,视网膜脱离[RD]占5.2%)。22525例患者中,第二眼PVD发生率为21.2%。诊断第二眼PVD的中位时间为37个月,其中74.5%的第二眼PVD患者在72个月内确诊。第二眼PVD的风险增加与第一眼VH (HR 1.08, p = 0.027)、第一眼RB (HR 1.13, p < 0.001)、双眼点阵变性(HR 1.09, p = 0.037)和第二眼假性晶状体(HR 1.21, p < 0.001)相关。年龄小于65岁(HR 0.79, p < 0.001)和男性(HR 0.93, p = 0.022)降低风险。33.2%的第二眼PVD患者有相关并发症,其中21.1%在12个月内被发现。危险因素包括男性(HR 1.46, p < 0.001)、双眼晶格变性(HR 1.38, p < 0.001)和第一只眼VH (HR 2.09, p < 0.001)、RB (HR 1.78, p < 0.001)或RD (HR 1.35, p = 0.004)。第一只眼PVD的任何并发症(HR 3.66, p < 0.001)都大大增加了风险。65岁降低并发症风险(HR 0.77, p < 0.001)。结论:继第一眼PVD后,第二眼PVD可能在数年后发生,特别是在年轻患者、第一眼VH和RB患者、第二眼假性晶状体患者和双眼晶格变性患者等高危人群中,需要持续随访。第二眼PVD发病后,由于第二眼PVD并发症的风险较大,男性患者、双眼晶格变性患者或有第一眼PVD并发症史的高危人群需要更密切和更长时间的随访。